Skip to main content
Clinical Trials/NCT05957523
NCT05957523
Recruiting
N/A

Effects of Remote Ischemic Preconditioning on Peripheral Blood Biomarkers in Healthy Adults (EMINENT): a Single-centre, Open-label, Randomized Controlled Clinical Trial

First Affiliated Hospital Xi'an Jiaotong University1 site in 1 country60 target enrollmentJune 27, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Ischemic Preconditioning
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Enrollment
60
Locations
1
Primary Endpoint
Comparison of changes in various biomarkers between intermediate and intense training group
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The aim of this study is to investigate the effects of remote ischaemic preconditioning on the peripheral blood characteristics of healthy adults and to explore the possible mechanisms for improving ischaemia/reperfusion injury and its protective effects on the cardiovascular system.

Detailed Description

This study plans to recruit 60 healthy volunteers, who will be randomly divided into a high-frequency group and a low-frequency group. The high-frequency remote ischemic preconditioning (RIPC) group will undergo RIPC training continuously for seven days, twice daily, with each session consisting of four cycles of 5 minutes of ischemia followed by 5 minutes of reperfusion. The low-frequency RIPC group will follow the same cycle and compression pattern but will train only once a day. Biological samples and physiological indicators will be collected from participants on the day just before the start of ischemic preconditioning training, as well as on the 7th and 14th days following the start of the training. These samples will be analyzed to identify the differences in blood components between groups and at different time points before and after RIPC. The study aims to investigate the effects of different training frequencies of RIPC on the characteristics of peripheral blood in healthy adults, as well as the changes in the peripheral blood characteristics of the participants before and after the training.

Registry
clinicaltrials.gov
Start Date
June 27, 2024
End Date
December 12, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Aged 18 to 45 years;
  • Be in good health;
  • Consent to participate in the clinical trial and sign the informed consent form.

Exclusion Criteria

  • Abnormal results in biochemical checks and physiological indicators.
  • Cardiovascular and cerebrovascular diseases: hypertension, coronary heart disease, congenital heart disease, cerebrovascular alterations, etc.
  • Endocrine diseases: diabetes, thyroid disorders, etc.
  • Hematologic diseases: anemia, paroxysmal hemoglobinuria, primary thrombocytosis, etc.
  • Infectious diseases: hepatitis B, hepatitis C, syphilis, etc.
  • Neurological and psychiatric disorders.
  • Vascular diseases: peripheral vascular disease, Raynaud's syndrome, thromboembolic diseases.
  • Major trauma or surgery within the last six months.
  • Pregnant or breastfeeding women.
  • Upper limbs unsuitable for compression treatment: history of upper limb surgery, presence of tissue damage and limb deformity, and concomitant hemorrhagic diseases.

Outcomes

Primary Outcomes

Comparison of changes in various biomarkers between intermediate and intense training group

Time Frame: Baseline (before training), the end of the training day (7th day from the start of training), 7th day after the end of training

Difference in collected materials from participants in group A (intermediate RIPC training, once a day) or B (intense RIPC training, twice a day)

Change of peripheral blood characteristics

Time Frame: Baseline (before training), the end of the training day (7th day from the start of training), 7th day after the end of training

Peripheral blood characteristics at different remote ischemic preconditioning, training time points, including different fractions and their characteristics expressed by the results of blood tests.

Change of gut microbiome components at different remote ischemic preconditioning training time points

Time Frame: Baseline (before training), the end of the training day (7th day from the start of training), 7th day after the end of training

Gut microbiome components

Secondary Outcomes

  • Change of faecal characteristics(Baseline (before training), the end of the training day (7th day from the start of training), 7rd day after the end of training)
  • Change of heart rates(Baseline (before training), during the training session (day1-7), 7th day after the end of training)
  • Incidence of adverse events(During day 1 to 7 of training.)
  • Change of blood pressure(Baseline (before training), during the training session (day1-7), 7th day after the end of training.)

Study Sites (1)

Loading locations...

Similar Trials